Tumor Biology

, Volume 35, Issue 1, pp 397–402 | Cite as

Effect of GSTM1 null genotype on risk of childhood acute leukemia: a meta-analysis

  • Yan Ma
  • Yun Sui
  • Lizhen Wang
  • Huirong Li
Research Article


Glutathione S-transferases are important enzymes in the detoxification of a wide range of reactive oxygen species. Recently, there have been a number of studies on the association between Glutathione S-transferase M1 (GSTM1) null genotype and childhood acute leukemia in Chinese, but the results of previous reports are inconsistent. Thus, we performed a meta-analysis to clarify the effect of GSTM1 null genotype on childhood acute leukemia risk. PubMed, Embase, and Wanfang databases were searched to identify case–control studies investigating the association between GSTM1 null genotype and risk of childhood acute leukemia. Between-study heterogeneity was assessed using the I 2 statistic method. Odds ratios (OR) with corresponding 95 % confidence intervals (95 % CI) were pooled to assess the association. Seven case–control studies were finally included in the meta-analysis. There was no between-study heterogeneity among those seven studies (I 2 = 0 %). Overall, the GSTM1 null genotype was significantly associated with increased risk of childhood acute leukemia in Chinese (fixed effect OR = 2.49; 95 % CI, 1.84–3.37; P < 0.001). The cumulative meta-analyses showed a trend of more obvious association between GSTM1 null genotype and risk of childhood acute leukemia in Chinese as data accumulated by year. Sensitivity analysis by omitting single study in turns also did not materially alter the pooled ORs. Therefore, the GSTM1 null genotype is significantly associated with increased risk of childhood acute leukemia in Chinese.


GSTM1 Acute leukemia Childhood Meta-analysis 


Conflicts of interests



  1. 1.
    Diller L. Clinical practice. Adult primary care after childhood acute lymphoblastic leukemia. N Engl J Med. 2011;365:1417–24.PubMedCrossRefGoogle Scholar
  2. 2.
    Creutzig U, van den Heuvel-Eibrink MM, Gibson B, Dworzak MN, Adachi S, de Bont E, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012;120:3187–205.PubMedCrossRefGoogle Scholar
  3. 3.
    Loh ML, Mullighan CG. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy. Clin Cancer Res. 2012;18:2754–67.PubMedCrossRefGoogle Scholar
  4. 4.
    Mullighan CG. Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest. 2012;122:3407–15.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Wiemels J. Perspectives on the causes of childhood leukemia. Chem Biol Interact. 2012;196:59–67.PubMedCrossRefGoogle Scholar
  6. 6.
    Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88.PubMedCrossRefGoogle Scholar
  7. 7.
    Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.PubMedCrossRefGoogle Scholar
  8. 8.
    Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart I, Vannais D, et al. Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet. 1993;53:220–33.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Li YH, Wen FQ, Xiao ZH, Chen YX, Zhang ZX, Chen LL. Genetic polymorphism of GST gene in children with infectious mononucleosis and acute lymphocytic leukemia. Zhongguo Dang Dai Er Ke Za Zhi. 2012;14:260–3.PubMedGoogle Scholar
  10. 10.
    Wang J, Zhang L, Feng J, Wang H, Zhu S, Hu Y, et al. Genetic polymorphisms analysis of glutathione S-transferase M1 and T1 in children with acute lymphoblastic leukemia. J Huazhong Univ Sci Technolog Med Sci. 2004;24:243–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Wu YX, Gao YJ, Zhao JC, Jing XP, Xia ZL. Preliminary study on polymorphism of GSTM1, CYP2E1 and NQO1 genes and risk factors of children leukemia. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:819.PubMedGoogle Scholar
  12. 12.
    Zou LL, Lin GF, Ma QW, Zhang DS, Shen JH. Glutathione s-transferase T1, M1 gene polymorphism in leukemia patients in Shanghai area. Zhonghua Zhong Liu Za Zhi. 2004;26:649–51.PubMedGoogle Scholar
  13. 13.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRefGoogle Scholar
  14. 14.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  15. 15.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  16. 16.
    Muellerleile P, Mullen B. Sufficiency and stability of evidence for public health interventions using cumulative meta-analysis. Am J Public Health. 2006;96:515–22.PubMedCrossRefGoogle Scholar
  17. 17.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Feng JF, Wang J, Zhang L, Luan B, Wang H. Gstm1, gstt1 gene polymorphisms and childhood acute myeloid leukemia susceptibility. Lab Med. 2004;19:260–2.Google Scholar
  19. 19.
    Jiang LJ, Tan GF. Association between the polymorphisms of cytochrome p4501a1 and glutathione S-transferase M1, T1 genes and childhood acute lymphocytic leukemia. Chin J New Clin Med. 2010;3:810–4.Google Scholar
  20. 20.
    Wang J, Xu Y, Fu Q, Yu J, Chen Z, Liu Z, et al. Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis. Tumour Biol. 2013;34:1431–40.PubMedCrossRefGoogle Scholar
  21. 21.
    Wei Y, Zhou T, Lin H, Sun M, Wang D, Li H, et al. Significant associations between GSTM1/GSTT1 polymorphisms and nasopharyngeal cancer risk. Tumour Biol. 2013;34:887–94.PubMedCrossRefGoogle Scholar
  22. 22.
    Zhang Y, Liu C. The interaction between smoking and GSTM1 variant on lung cancer in the chinese population. Tumour Biol. 2013;34:395–401.PubMedCrossRefGoogle Scholar
  23. 23.
    Wang H, Wang J, Zhao L, Liu X, Mi W. Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies. BMC Med Genet. 2012;13:77.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Zhuo W, Zhang L, Zhu B, Qiu Z, Chen Z. Association between CYP1a1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls. PLoS One. 2012;7:e46974.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of PediatricsShandong Jiao Tong HospitalJinan CityChina
  2. 2.Department of Internal MedicineSecond People’s Hospital of Jinan CityJinan CityChina
  3. 3.Department of Gynecology and ObstetricsShandong Jiao Tong HospitalJinan CityChina

Personalised recommendations